Session 11: Tumours of the Reproductive Tracts NOT FINISHED Flashcards

1
Q

Where might you find tumours in the female reproductive tracts?

A

Vulva

Cervix

Endometrium

Myometrium

Ovaries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a tumour?

A

Any clinically detectable lump or swelling. A neoplasm is just one type of tumour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a neoplasm?

A

An abnormal growth of cells that persists after the initial stimulus is removed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a malignant neoplasm?

A

An abnormal gorwth of cells that persists after the initial stimulus is removed and invades surrounding tissue with potential to spread to distant sites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Most common vulval cancers.

A

Squamous cell carcinoma (90%)

Basal cell carcinoma

Melanoma

Soft tissue tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical features of vulval cancers.

A

Lumps

Ulceration

Skin changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What might you find upon histological investigation of squamous cell carcinoma of vulva?

A

Atypical squamous cells and keratin formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is vulval intraepithelial neoplasia a potential precursor of?

A

Squamous cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the main causative factor of squamous cell carcinoma of the vulva in pre-menopausal women?

A

HPV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where does the SCC spread?

A

Direct to anus, vagina and bladder

Lymph nodes such as inguinal, iliac and para-aortic

Distant metastases to lung and liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the causative agent of vulval squamous cell carcinoma in older women?

A

Not known but probably related to chronic irritation and long standing dermatoses such as lichen sclerosus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is dysplasia?

A

A pre-neoplastic alteration in which cells show disordered tissue organisation.

It is not neoplastic because the change is reversible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What type of cancer is most common of the cervix?

A

Squamous cell carcinomas (80%)

15% are adenocarcinomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Most common causative agent of cervical cancer.

A

Almost exclusively HPV (99.5%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does squamous cell carcinoma develop from?

A

Cervical intraepithelial neoplasia (CIN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain how HPV causes cancer of the cervix.

A

Infect the transformation zone

Produce viral proteins E6 and E7 that inactivate TSGs p53 and Rb.

This leads to uncontrolled cellular proliferation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Risk factors for CIN and cervical carcinoma

A

Increased risk of exposure to HPV such as sexual partner with HPV, multiple partners or early age of first intercourse.

Early first pregnancy

Multiple births

Smoking

Low socio-economic status

Immunosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Treatment for CIN

A

Depends on which stage of CIN.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Treatment of CIN1.

A

Most commonly regress spontaneously but is followed up by a cervical smear in 1 year time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Treatment of CIN 2&3.

A

Needs treatment and is done by large loop excision of transformation zone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the cervical screening programme?

A

Brush is used to scrape cells from the transformation zone to detect abnormally enlarged nuclei possessing abnormal chromatin. If this is positive there is referral to colposcopy.

You also test for HPV.

Aged 25-49 = every 3 years

Aged 50-64 = every 5 years

Over 65 = only if recent abnormality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is vaccination against HPV?

A

Given in girls aged 12-13 and becomes more common in boys as well.

Protects from cervical, vulval, oral and anal cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How do carcinomas of cervix spread?

A

Spreads initially to iliac and aortic lymph nodes before wider systemic dissemination.

Spread locally to ureters, bladder, and rectum.

Can be extremely distressing with pain and fistula formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Clinical presentation of invasive cervical cancer.

A

Bleeding post coital, intermenstrual and post menopausal.

Mass felt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Treatment of invasive cervical cancer.
Hysterectomy Lymph node dissection +/- chemoradiation
26
What types of endometrial cancers are there?
Endometrioid adenocarcinoma Serous adenocarcinoma
27
What does endometrioid adenocarcinoma commonly arise from?
Endometrial hyperplasia
28
Which age group is generally affected by endometrioid adenocarcinoma?
Perimenopausal and older women.
29
Aetiology of endometrial adenocarcinoma in perimenopausal women.
Unopposed oestrogen from obesity, exogenous oestrogen administration like HRT. Tamoxifen Hormone-secreting tumour Polycystic ovarian syndrome Early menarche/late menopause (longer exposure to oestrogen)
30
How can obesity cause a higher risk of endometrial hyperplasia and endometrial adenocarcinoma?
Peripheral adipocytes cause conversion of androgen to oestrogen leading to higher oestrogen levels.
31
Clinical presentation of endometrial cancer.
Bleeding that is post menopausal. Intermenstrual bleeding Mass
32
How do serous adenocarcinomas differ to endometrioid carcinoma?
Serous are less common and more aggressive.
33
What is the spread of endometrioid adenocarcinoma?
Cervix, bladder and rectum. Through the peritoneal cavity and to the regional lymph nodes.
34
Spread of serous adenocarcinoma.
Travels through fallopian tubes. Deposits on peritoneal surface via transcoelomic spread. Associated with collections of calcium called psammoma bodies.
35
Management of endometrial cancer.
Hysterectomy Bilateral salpingo-oophorectomy +/- lymph node dissection +/- chemoradiotherapy
36
What are fibroids?
Leiomyoma which are the most common of the myometrium and benign.
37
Symptoms of fibroids
Heavy menstrual loss, menorrhagia and infertility
38
Appearance of fibroids.
Pale, homogenous, well circumscribed mass
39
What can fibroids cause?
Massive uterine enlargement and this results in pressure symptoms in the pelvis. The growth is oestrogen dependent and they usually regress after the menopause.
40
What is a malignant tumour of the myometrium?
Leiomyosarcoma
41
Do leiomyosarcomas arise from leiomyomas?
No
42
Metastases of leiomyosarcoma.
Spread via blood stream to the **lungs**
43
Presentation of ovarian cancer.
Vague and non-specific. Later symptoms like abdo pain, abdo distension, urinary symptoms and GI symptoms due to mass effect. Hormonal disturbances
44
Give types of ovarian tumours.
Surface epithelium (epithelial tumours) Germ cell tumours Sex-cord stromal tumours
45
What are the majority of ovarian tumours?
Epithelial tumours
46
Serum marker of ovarian cancer.
Ca-125
47
Cause of ovarian epithelial carcinoma.
BRCA1/2 which are TSGs associated with high grade serous cancers.
48
What are the histological subtypes of ovarian epithelial tumours.
Serous Mucinous Endometroid All adenocarcinomas All can be benign, borderline or malignant
49
Ovarian serous adenocarcinoma with highly atypical cells often show **psammoma bodies**. Often spreads to the peritoneal cavity
50
Ovarian mucous adenocarcinoma showing atypical cells secreting mucin.
51
Ovarian endometrioid adenocarcinoma Glands resembling **endometrium** and may arise in endometriosis.
52
Most common female germ cell tumour.
Teratoma
53
Three subtypes of teratoma
Mature Immature Monodermal
54
What do mature teratomas (dermoid cyst) look like on histology?
Contain fully mature differentiated tissue from all germ cells layers. Often contains skin + hair
55
What does the presence of immature tissue such as primitve neuroepithelium indicate?
Malignancy and a risk for intra-abdominal spread.
56
Give other malignant germ cell tumours.
Dysgerminomas which are the equivalent of seminoma in testis. Choriocarcinoma Embryonal carcinoma Yolk sac tumour
57
Useful tumour markes in malignant germ cell tumours.
Alpha-fetoprotein (AFP) beta-human chorionic gonatrophin (hCG)
58
Sex cord stromal tumours in testes
Sertoli cell tumour Leydig cell tumour
59
Sex cord stromal tumours in ovaries.
Granulosa cells Theca cells
60
What do granulosa cell tumours produce?
Oestrogens that may be responsible for endometrial hyperplasia and adenocarcinoma as it can lead to endometroid adenocarcinoma.
61
What do sertoli-leydig cell tumours produce?
Androgens that can cause defeminisation, masculinisation, amenorrhoea and infertility.
62
What might theca and granulosa cell tumours cause in a patient pre-puberty?
Precocious puberty
63
What might theca and granulosa cell tumours cause in a patient post-puberty?
Breast cancer Endometrial hyperplasia Endometrial carcinoma
64
What might Sertoli-Leydig cell tumours cause in a patient pre-puberty?
Prevents normal female pubertal changes
65
What might Sertoli-Leydig cell tumours cause in a patient post-puberty?
Sterility Amenorrhoea Hirsuitism Male pattern baldness Breast atrophy
66
Common cancers metastasising **to** ovaries.
Breast cancer Gastrointestinal cancers Krukenberg tumour (metastatic GI tumour) Other gynae tumours endometrial, other ovary, fallopian tube
67
When in men are tumours of the testis most common?
Aged 15-34
68
What can testicular tumours be classified as?
Germ cell tumours Sex-cord stromal tumours
69
What are the most common sex cord stromal tumours in men?
Sertoli or Leydig cell tumours
70
Are sex cord-stromal tumours malignant or benign?
Benign and also very uncommon
71
What are the most common testicular tumours?
Germ cell tumours (they are also all malignant)
72
Risk factors of testicular cancer.
Cryptorchidism which is an undescended testicle. That's why it is important to ask for medical history
73
Presentation of testicular cancer.
Mass Usually painless testicular mass but might be painful.
74
What is the pre-invasive precursor of germ cells tumours?
Intratubular germ cell neoplasia
75
What can germ cell tumours be divided into?
Seminomas Non-seminomatous germ cells tumours (NSGCTs)
76
What percentage of germ cell tumours are seminomas?
50%
77
Peak age of seminomas
40-50 yrs of age
78
What can pure NGSCTs be classified as?
Yolk sac tumours Embryonal carcinomas Choriocarcinomas Teratomas However most NSGCTs are mixed
79
Yolk sac tumours
Occur in young children and have very good prognosis
80
Investigations of testicular cancers
Scans and tumour markers
81
What do yolk sac tumours produce?
AFP
82
Embryonal carcinomas, choriocarcinomas, and mixed NGSCTs
Occur in young adults
83
What do choriocarcinomas produce?
beta-human chorionic gonadotropin (hCG)
84
What do mixed NSGCTs produce?
AFP and hCG
85
Teratomas in men
Occur in all ages. Arise in prepubertal then usually benign, if in postpubertal always malignant.
86
Seminomas
10% are also associated with raised serum hCG.
87
Spread of seminomas
Remain confined to the testis for long periods of time. However when they do metastasise it is by the lymphatics and most commonly to the **iliac** and **paraortic lymph nodes**. Further spread is rare.
88
Spread of NSGCTs.
Tend to metastasise early and do so via both lympathics and blood. The primary tumour might even be non-palpable.
89
Treatment of testicular tumours.
Radical orchiectomy
90
Further treatment of testicular tumours
Depends on whether the tumour is seminoma or NSGCT.
91
Further treatment of a seminoma.
Radiosensitive and treated therfore with radiotherapy.
92
Further treatment of NSGCTs.
Aggressive chemotherapy